JVMCX
Price
$28.19
Change
+$0.04 (+0.14%)
Updated
Oct 3 closing price
Net Assets
24.36B
LMCPX
Price
$32.78
Change
+$0.13 (+0.40%)
Updated
Oct 3 closing price
Net Assets
1.14B
Interact to see
Advertisement

JVMCX vs LMCPX

Header iconJVMCX vs LMCPX Comparison
Open Charts JVMCX vs LMCPXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$28.19
Change+$0.04 (+0.14%)
VolumeN/A
Net Assets24.36B
Lord Abbett Mid Cap Stock P
Price$32.78
Change+$0.13 (+0.40%)
VolumeN/A
Net Assets1.14B
JVMCX vs LMCPX Comparison Chart in %
View a ticker or compare two or three
VS
JVMCX vs. LMCPX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Hold and LMCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 24.4B vs. LMCPX (1.14B). LMCPX pays higher dividends than JVMCX: LMCPX (0.36) vs JVMCX (0.00). JVMCX was incepted earlier than LMCPX: JVMCX (14 years) vs LMCPX (28 years). JVMCX (1.86) is less costly to investors than LMCPX (1.23). LMCPX is a more actively managed with annual turnover of: 53.00 vs. JVMCX (49.00). LMCPX has a lower initial minimum investment than JVMCX: LMCPX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -1.64 vs. LMCPX (-7.22). JVMCX return over 5 years is better than : 50.05 vs. LMCPX (42.21).
JVMCXLMCPXJVMCX / LMCPX
Total Expense Ratio1.851.23150%
Annual Report Gross Expense Ratio1.861.23151%
Fund Existence14 years28 years-
Gain YTD11.4231.486769%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets24.4B1.14B2,148%
Annual Yield % from dividends0.000.36-
Returns for 1 year-1.64-7.2223%
Returns for 3 years23.0120.66111%
Returns for 5 years50.0542.21119%
Returns for 10 years45.3340.90111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVCNF0.18N/A
+0.88%
Avicanna Inc.
IPHYF2.00N/A
N/A
Innate Pharma
OSSUY4.00N/A
N/A
EMBLA MEDICAL
SIEVF191.00N/A
N/A
D IETEREN GROUP NV
NBKCF19.16N/A
N/A
National Bank of Canada